Biosafe, a company headquartered in Switzerland that manufactures processing technologies for stem cell banking and regenerative medicine, has launched its newest cell processing system called Smart-Max. The fully automated Smart-Max system, which has a touch screen interface, can be used for cell mixing, cooling, thawing, dilution, incubation and digestion. The Smart-Max system is used in tandem with the recently launched Sepax 2 system that can efficiently process umbilical cord blood, bone marrow, peripheral blood or any other blood-like material.
The two systems together offer full automation of all cell processing steps ranging from storage to cell transplant preparation. The device, which can handle cell bags of various sizes for processing, is seen as the final addition to Biosafe’s Coolmix family of devices.
Press release: Biosafe’s Latest Innovation: Smart-Max…